title: Adjuvant sorafenib for liver cancer: wrong stage, wrong dose.
authors.affiliation: University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA. Electronic address: katie.kelley@ucsf.edu.
authors.forename: Robin Kate
authors.initials: RK
authors.lastname: Kelley
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000601:surgery*; D017115:Catheter Ablation; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D009536:Niacinamide